Weight does not simply snap back when patients stop Ozempic and similar GLP-1 drugs, according to a new Cleveland Clinic analysis of almost eight thousand records from Ohio and Florida. The dataset tracks people who discontinued GLP-1 prescriptions and then stayed in structured obesity care programs.Researchers report that many patients did regain some weight, but the pattern depended heavily on f...More